openPR Logo
Press release

Depression Devices Market Analysis Focuses on Innovations & Opportunities Experienced Across Major Economies, reports Fact.MR // Neuro-Fitness LLC, Brainsway Ltd, Electromedical Products International, Inc., and MagVenture A/S.

05-24-2019 01:47 PM CET | Industry, Real Estate & Construction

Press release from: Fact.MR

Depression Devices Market Analysis Focuses on Innovations &

Depression is characterized by multiple mental health challenges including lack of positivity, suicidal thoughts, anxiety, insomnia, overeating/loss of appetite, and sadness. Extension of such feelings for a longer duration turns into a serious condition, which results in depression.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=575

Increase in the stressful lifestyles further induces anxiety and sleeplessness, which if left untreated causes severe health threats and even results into suicides. Growing number of depression diagnosed population is generating a pressing need for an effective cure and consumers have been preferring medication to recover from depression. However, numerous studies reporting side-effects of depression drugs have unlocked new avenues for the manufacturers operating in the Depression Devices Market, which is expected to deliver sustained growth to the depression devices market in the upcoming years.

Depression Devices Market – Novel Developments

Some of the significant partakers bringing innovation in the depression devices market encompass Fisher Wallace, Boston Scientific Corporation, Neuro-Fitness LLC, Brainsway Ltd, Electromedical Products International, Inc., and MagVenture A/S. Realizing the side-effects caused by the drugs, manufacturers operating in the depression devices market have been capitalizing on the opportunity to offer effective treatment without medication.

Electromedical Products International, Inc. developed an FDA approved depression device, Alpha-Stim®, which boasts a capability to treat depression easily, safely, and quickly. The recommended duration for the use of this device is 20 minutes, however, there is no risk associated with its overuse, which enhances its desirability.

In 2018, MagVenture developed a magnetic stimulation device that claims to treat depressed patients in as little time as 3 minutes. The non-invasive therapy delivers magnetic waves to activate nerve cells, which in turn excites the neurons and alters their mood.

In 2018, a Swedish company – Flow Neuroscience, developed a wearable for depression treatment that involves attaching two electrodes to the sides of the forehead and a weak electrical signal is transmitted to the brain. The company is further set to leverage the online distribution channel for the sales of this device and its availability without the prescription of medical personnel is believed to proliferate its adoption rate.

To know more about the Depression Devices Market Visit the link- https://www.factmr.com/report/575/depression-devices-market

With the widespread prevalence of depression, governments of numerous countries have been readily granting approvals to the depression devices. This has offered a leeway to manufacturers to develop therapeutic devices and increase their sales prospects with this reduced time-to-market. As a result, portable depression devices that lend convenience to patients are gaining notable traction. Increasing adoption rate of these devices has also been witnessed, on account of the devices being non-invasive.

Another crucial driver delivering growth to the depression devices market is streamlined distribution channel. Traditionally, the stimulation therapies were performed by the medical practitioners and their availability were restricted to only hospitals, homecare settings, rehabilitation centers, and clinics. However, depression devices driven by innovation have resulted in various high-end wearable devices, which can be plugged in and operated without the supervision of doctors.

In the future, with the incessant growth of ecommerce portals, sales of depression devices will be easier with their online availability. As a result, regions without any proper depression treatments will, in turn, be able to access these devices, which is anticipated to bode well for the growth of the depression devices market.

North America to Remain an Affluent Market for the Growth of the Depression Devices Market

Geographically, North America is anticipated to contribute the largest share to the depression devices market with a perpetual rise in the stressful lifestyle resulting in a growing number of depressed individuals. In addition, the high concentration of significant partakers working towards developing user-friendly devices is anticipated to maintain its influence on the depression devices market in the forthcoming years. Next in the market, Europe possesses lucrative growth opportunities for the depression devices market with an excellent adoption rate of these devices to offer therapies for treating depression.

Depression Devices Market: Overview

Depression device are very affective for patients suffering from various depression such as, persistent depressive disorder, psychotic depression, postpartum depression, major depression, seasonal affective disorder and others. Various public and private research institutes are working for developing more affective device to recover depression patient and connect them to normal lifestyle. The players are also developing more portable device, so that the depression patient can carry the device for point of care in any time.  

Depression Devices Market: Region-wise Outlook

Geographically, Depression devices market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America is a major market as the major players are present in the region and the patient pool is also increasing every year. Europe is accepting depression device to provide therapy to recover depression device. Asia Pacific is slowing sluggish growth as the healthcare professional are adapting depression device. In, Middle East and Africa the awareness programs are increasing about the product and the medical use for recover depression patients.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=575

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Depression Devices Market Analysis Focuses on Innovations & Opportunities Experienced Across Major Economies, reports Fact.MR // Neuro-Fitness LLC, Brainsway Ltd, Electromedical Products International, Inc., and MagVenture A/S. here

News-ID: 1752592 • Views:

More Releases from Fact.MR

USB Wall Charger Market to Witness Exponential Growth, Expected to Hit US$ 3.09 Billion by 2033 at 6.3% CAGR
USB Wall Charger Market to Witness Exponential Growth, Expected to Hit US$ 3.09 …
As of 2023, the USB wall chargers market was valued at US$ 1.68 billion worldwide. By the end of 2033, the global market for USB wall chargers is expected to be valued US$ 3.09 billion, growing at a compound annual growth rate of 6.3%. The rapid spread of the Internet throughout different locations is credited with creating growth potential in the global industry. It is also anticipated that the significant power
Organic Fertilizer Market is Set to Hit US$ 16,673.5 Million at a CAGR of 6.4% by 2034: Fact.MR Report
Organic Fertilizer Market is Set to Hit US$ 16,673.5 Million at a CAGR of 6.4% b …
According to Fact.MR, the organic fertilizer market is anticipated to expand at a 6.4% CAGR between 2024 and 2034. The global market for these goods is anticipated to grow to US$ 16,673.5 million by 2034. Market research and competitive intelligence firm Fact MR states that the worldwide organic fertilizer market is expanding quickly and is predicted to maintain this development trajectory in the upcoming years. The organic fertilizer industry can see
Home Healthcare Market to Cross US$ 8,78,383.5 Million, Rising at a CAGR of 9.8% by 2034: Fact.MR Report
04-18-2024 | Health & Medicine
Fact.MR
Home Healthcare Market to Cross US$ 8,78,383.5 Million, Rising at a CAGR of 9.8% …
The global home healthcare industry is expected to be worth US$3,45,256.6 million in 2024. Through 2034, the market is expected to expand rapidly at a 9.8% CAGR. By 2034, the market is expected to grow to US$ 8,78,383.5 million. There is an increasing need for in-home healthcare services as the number of senior people rises. Additionally, there is a growing need for the specialized care provided by home healthcare professionals due
CAR T-Cell Therapy Market Size is Expected to Reach a Value of US$ 11.49 Billion by 2034: Fact.MR Report
04-18-2024 | Health & Medicine
Fact.MR
CAR T-Cell Therapy Market Size is Expected to Reach a Value of US$ 11.49 Billion …
The market for CAR T-cell treatment is expected to grow at an astounding 17.7% CAGR from 2024 to 2034, with a projected valuation of US$ 2.25 million in 2024. Increased leukemia incidence, a surge in research and development to generate novel CAR T-cell therapy, and CAR T-cell therapy's better efficacy over other conventional cancer treatments are the main factors driving the market growth for CAR T-cell therapy. 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟

All 5 Releases


More Releases for Depression

Increase in the prevalence of anxiety disorders and depression is bolstering the …
The research report "Global Anxiety Disorders and Depression Treatment Market: By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2028." The global anxiety disorders and depression treatment market size was valued at USD 8.2 Bn in the year
Depression Treatment Device Market: Information by Product Type (Light Therapies …
Depression is characterized by multiple mental health challenges that involve a lack of positivity, suicidal thoughts, insomnia, anxiety, loss of appetite, and sadness. Depression is caused by a combination of biological, genetic, environmental, and psychological factors. Globally, the prevalence of depression is increasing at an alarming rate. About 300 million people of all ages suffered from depression and the suicide rate rose to about 8,00,000 individuals in 2018. As per
Depression Cannot Hit A Moving Target
Cottonwood Heights, Utah, Mar 12, 2020 -- Depression can't hit a moving target. That was a phrase to live by for Chelsea Hansen. She was full of life and love, and she had big goals. But soon she was to discover that life doesn't turn out the way she planned. Behind the Fake Smile is a fictional book based on real-life experiences. It's the story of how Chelsea navigates a world
Depression Drugs Market: Increase in Cases of Depression to Boost Market Growth
Transparency Market Research (TMR) has published a new report titled, “Depression Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global depression drugs market was valued at US$ 6,500 Mn in 2017 and is anticipated to decline at a CAGR of 2% from 2018 to 2026. The report suggests that rise in incidence of major depression disorders is projected to drive
Depression Therapeutics Market Forecast till 2025
Antidepressants are used to treat a wide range of mental disorders, including depression, anxiety, and major depressive disorder. Certain neurotransmitters in the brain exist in chemical form such as dopamine and serotonin, which are responsible for maintaining emotional balance such as mood and behavior. Antidepressants cover a wide range of drug categories, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants
Depression Drug Market: Global Depression Drug Forecast Will Reach $16.8 billion …
Zion Market Research has published a new report titled “Depression Drug (Benzodiazepines, SNRIs, TCAs, TeCAs, Atypical Antipsychotics, Monoamine Oxidase inhibitors and Others) Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020” According to the report, the global depression drug market was valued at USD 14.51 billion in 2014 and is expected to generate revenue of USD 16.8 billion by end of 2020, growing at a CAGR of 2.50%